SCORED, SOLOIST Studies Provide Evidence for Treatment of Diabetes with SGLT2 InhibitorsTwo large clinical studies conducted by researchers at Brigham and Women's Hospital are...
SAN DIEGO, February 3, 2021 / PRNewswire / - ViaCyte, Inc., a clinical-stage regenerative medicine company, announced today that the first patients with...